124 related articles for article (PubMed ID: 38507231)
1. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
2. The development of nanocarriers for natural products.
Huang L; Luo S; Tong S; Lv Z; Wu J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1967. PubMed ID: 38757428
[TBL] [Abstract][Full Text] [Related]
3. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma.
Naser IH; Zaid M; Ali E; Jabar HI; Mustafa AN; Alubiady MHS; Ramadan MF; Muzammil K; Khalaf RM; Jalal SS; Alawadi AH; Alsalamy A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3747-3770. PubMed ID: 38095649
[TBL] [Abstract][Full Text] [Related]
4. Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems.
Singh D
Assay Drug Dev Technol; 2024; 22(4):203-215. PubMed ID: 38717194
[No Abstract] [Full Text] [Related]
5. Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders.
Acharya B; Behera A; Behera S; Moharana S
ACS Appl Bio Mater; 2024 Mar; 7(3):1336-1361. PubMed ID: 38412066
[TBL] [Abstract][Full Text] [Related]
6. Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent-loaded nanoparticles.
Siddiquee T; Bhaskaran NA; Nathani K; Sawarkar SP
Phytother Res; 2024 May; ():. PubMed ID: 38806412
[TBL] [Abstract][Full Text] [Related]
7. Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis.
Balaji PG; Bhimrao LS; Yadav AK
Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38829514
[TBL] [Abstract][Full Text] [Related]
8. Materials innovation for co-delivery of diverse therapeutic cargos.
Godsey ME; Suryaprakash S; Leong KW
RSC Adv; 2013 Dec; 3(47):24794-24811. PubMed ID: 24818000
[TBL] [Abstract][Full Text] [Related]
9. Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy.
Chary PS; Shaikh S; Rajana N; Bhavana V; Mehra NK
Biomater Adv; 2024 May; 162():213903. PubMed ID: 38824828
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology: The Future for Diagnostic and Therapeutic Intervention in Cardiovascular Diseases is Here.
Elsaygh J; Zaher A; Parikh MA; Frishman WH; Peterson SJ
Cardiol Rev; 2024 May; ():. PubMed ID: 38814069
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology.
Zygmunt A; Gubernator J
Expert Opin Drug Deliv; 2024 Jun; ():1-21. PubMed ID: 38899424
[TBL] [Abstract][Full Text] [Related]
12. Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy.
Sun L; Li Z; Lan J; Wu Y; Zhang T; Ding Y
Front Pharmacol; 2024; 15():1389922. PubMed ID: 38831883
[TBL] [Abstract][Full Text] [Related]
13. To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges.
Wehn AC; Krestel E; Harapan BN; Klymchenko A; Plesnila N; Khalin I
J Control Release; 2024 Jul; 371():216-236. PubMed ID: 38810705
[TBL] [Abstract][Full Text] [Related]
14. A neoteric annotation on the advances in combination therapy for Parkinson's disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus.
Unnithan D; Sartaj A; Iqubal MK; Ali J; Baboota S
Expert Opin Drug Deliv; 2024 Mar; 21(3):437-456. PubMed ID: 38507231
[TBL] [Abstract][Full Text] [Related]
15. A neoteric annotation on the advances in combination therapy for Parkinson's disease: nanocarrier-based combination approach and future anticipation. Part I: exploring theoretical insights and pharmacological advances.
Unnithan D; Sartaj A; Iqubal MK; Ali J; Baboota S
Expert Opin Drug Deliv; 2024 Mar; 21(3):423-435. PubMed ID: 38481172
[TBL] [Abstract][Full Text] [Related]
16. Micro- and nanotechnology approaches to improve Parkinson's disease therapy.
Torres-Ortega PV; Saludas L; Hanafy AS; Garbayo E; Blanco-Prieto MJ
J Control Release; 2019 Feb; 295():201-213. PubMed ID: 30579984
[TBL] [Abstract][Full Text] [Related]
17. Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease.
Gunay MS; Ozer AY; Chalon S
Curr Neuropharmacol; 2016; 14(4):376-91. PubMed ID: 26714584
[TBL] [Abstract][Full Text] [Related]
18. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
